Fundraising Fox

AgilVax

Albuquerque, US · Founded 2011 · Delaware corporation · 1 known investors

agilvax.com ↗
Biotech

Founders & leadership

JP
Joseph PattiNamed on SEC filing
EP
Ebetuel PallaresNamed on SEC filing
FC
Faith CharlesNamed on SEC filing
DE
Debora E RamirezNamed on SEC filing
BE
Bill EnloeNamed on SEC filing
SR
Stuart RoseNamed on SEC filing
WC
Waneta C TuttleNamed on SEC filing
FP
Federica PericleNamed on SEC filing

Board

WTWaneta Tuttle
Waneta TuttleinBoard directorFounder and Managing Partner at Tramway Venture Partners
BB
Brian BirkBoard director
BVBrad Vale
Brad ValeinBoard directorFounding General Partner at Treo Ventures, Llc
DB
Dee BresciaBoard directorAdministrative Services at Tramway Venture Partners

Investors · 1

Tramway Venture PartnersreportedNew Mexico · $30Mvia Waneta Tuttle · board

Reported raises · per SEC filings

Form D private placements

$4.2M disclosed across 2 rounds · 2014–2018

▶$3MraisedAug 2019 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph PattiExecutive Officer, Director
  • Waneta TuttleDirector
  • Ebetuel PallaresExecutive Officer, Director
  • Brian BirkExecutive Officer, Director
  • Faith CharlesDirector
  • Brad ValeDirector
  • Dee BresciaExecutive Officer
  • Debora E RamirezExecutive Officer
Offering amount
$7.5M
Amount sold
$3M
Minimum investment
$100K
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedJun 2014 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bill EnloeDirector
  • Stuart RoseDirector
  • Brian BirkDirector
  • Waneta C TuttleDirector
  • Federica PericleExecutive Officer, Director
  • Ebetuel PallaresDirector
Offering amount
$5M
Amount sold
$1.1M
Proceeds to insiders
$600K
First sale
Jun 2014
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$298.9K
National Institutes of Health (NIH)National Institutes of HealthPhase I2016$286.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who are AgilVax's investors?
AgilVax's investors include Tramway Venture Partners.
How much funding has AgilVax raised?
AgilVax has disclosed $4.2M raised across 2 rounds.
Where is AgilVax headquartered?
AgilVax is headquartered in Albuquerque, US.